wallless最新版-雷霆加速免费永久

Cervical cancer is the second most common cancer among women aged 15 to 44, affecting more than 500,000 women a year.1 Fortunately, it is almost 100% preventable through advanced screening and early detection of precancer before the disease becomes a danger to a patient’s life or reproductive health.

QIAsure, the new Women’s Health solution from QIAGEN, is a cervical cancer screening test that lets clinicians see what’s happening at a molecular level to determine whether cervical cells are actively transforming into cancer. This innovative test objectively detects the presence of biomarkers associated with cervical precancer and cancer in the PCR lab, using the same sample from an HPV or liquid-based cytology test. Whether the result is positive or negative, QIAsure can provide peace of mind for patients so they can live their lives safe, confident, and sure of their reproductive health.

wallless最新版-雷霆加速免费永久

Download a brochure for more information

wallless最新版-雷霆加速免费永久

Today, women have an 80% chance in their lifetimes of contracting high-risk HPV, the causal agent of cervical cancer. However, only 1 in 10 women with high-risk HPV will develop long-lasting infections that put them at risk for development of cervical cancer.2 There is growing need for an accurate molecular test to see beyond HPV and determine whether a patient has a high short-term risk of cervical cancer.

次元连接加速器_次元连接二次元加速器_次元连接吧:2021-9-7 · 次元连接 二次元游戏加速器 - 蜗牛娱乐网 2021年9月7日 - 次元连接 二次元游戏加速器时间:2021-09-07 来源:本站原创 作者:蜗牛 -小 +大安卓手游加速器,大部分都是日服游戏,主流日服游戏都有,目前 …

QIAsure could:

  • 如何加速访问国外服务器? -「云杰通信」:今天 · 如何加速访问国外服务器? 2021-06-18 17:04:25 云杰小编 阅读：11 企业用户在与海外企业对接时，访问海外服务器遇到了十分严重的问题。对于大部分之前一直访问国内服务器，甚至是没国外服务器的用户。在访问国外服务器的时候总会有很多的顾虑 ...
  • Guide surveillance and treatment decisions
  • Prevent women with non-transforming infections from receiving unnecessary treatments

wallless最新版-雷霆加速免费永久

SSR加速器怎么用？安全使用SSR加速器的一些注意事项 ...:2021-12-21 · SSR加速器使用注意事项之SSR加速器客户端篇 国内各大科技厂商，窥探隐私的欲望比较强烈，有鉴于此： 1.无论是电脑还是手机科学上网，建议不要安装国产杀毒软件。

可伡加速国外软件的加速器

QIAsure is a quantitative methylation specific (qMSP) test that looks for specific molecular biomarkers in cervical specimens to objectively detect the presence of biomarkers associated with cervical carcinoma and advanced transforming cervical intraepithelial neoplasia (CIN). The presence of these biomarkers (specifically hypermethylation of host cell genes FAM19A4 and miR124-2) indicates a carcinogenic cell transformation and a high short-term risk of developing cervical cancer.3–8 Absence of these biomarkers indicates a low short-term risk of developing cervical cancer. This test can be performed in the PCR lab through industry-standard methods of sample prep/extraction and automation platforms for analysis (clinically validated for Rotor-Gene® Q MDx instrument).

QIAsure has been shown to detect the transformation of cervical cells and advanced transforming CIN 2/3 lesions, even in patients with normal cytology.

wallless最新版-雷霆加速免费永久

QIAsure is a quantitative methylation specific PCR test with high sensitivity and 100% accuracy in detecting biomarkers associated with cervical carcinoma in patients.

可伡连接国外网的软件

QIAsure provides objective results on whether a patient has a hrHPV infection that’s actively transforming cervical cells into cancer.

QIAsure can be performed on the same sample (self-sample or physician/OBGYN collected) as the primary screening HPV test.

QIAsure can help reduce unnecessary colposcopies and cervical treatments.

QIAsure can be performed on self-samples collected by the patient without a speculum exam, making it easy and convenient to be tested early and often.

QIAsure provides test negative patients with peace of mind that they have a low short-term risk of cervical cancer.

Veronica has a high-risk HPV infection and returns for her six-month follow-up appointment. A pap smear discovers abnormal cytology and she undergoes colposcopy to look for precancerous lesions. Low-grade lesions are present, however the level of short-term risk is unclear since there are no molecular insights into whether the lesions are actively transforming into cancer or could subside on their own. QIAsure is performed for more insight into what’s happening at a molecular level before making a clinical decision for Veronica. Veronica 连接国外软件加速器
六毫秒加速器App-六毫秒加速器下载 1.0.1 安卓版-新云软件园:2021-6-12 · 六毫秒加速器是成都俊云科技有限公司打造的一款方便快捷的加速器软件，限时试用加速玩国服游戏、浏览国内视频，直播、音乐等各大主流平台，听歌追剧刷视频，低延迟极速畅联玩到爽，欢迎下 … Sophie age 32
Emma has high-risk HPV, but normal cytology. A QIAsure test produces a positive result, indicating the presence of transforming precancer. Emma is sent straight to colposcopy and treated for advanced transforming precancerous lesions. Without the QIAsure test, she would have had to wait 6 months before being re-tested, putting her life and reproductive health at risk. QIAsure identifies transforming high-risk HPV infections that can be missed by cytology and genotyping so that Emma is safe from dangerous precancer that could have rapidly progressed to cancer. Emma age 34